The market for hormones in dosage forms, excluding contraceptives and antibiotics in Poland, displayed fluctuations over the years. By 2023, the market size stood at $531.41 million. The sector experienced a decrease over the last two years, with a 0.75% decline from 2022 to 2023, following a significant 9.78% drop from 2021 to 2022. The five-year compound annual growth rate (CAGR) was around -0.77% up to 2023, indicating a downward trend.

Future trends to watch for include:

Potential technological advancements in hormonal therapies.
Increasing demand for innovative and personalized treatment options.
Regulatory changes impacting product availability and market stability.
Shifting demographics and associated healthcare needs influencing market dynamics.